Gastrin-releasing peptide receptor: a potential target in treatment of IBD?
Daniel C
DC
Damin
Frederico S
FS
Santos
Renata
R
Heck
Gilberto
G
Schwartsmann
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001839:Bombesin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D010446:Peptide Fragments / Q000627:therapeutic use*; D051381:Rats; D018004:Receptors, Bombesin / Q000037:antagonists & inhibitors*; D015398:Signal Transduction; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D005765:Gastrointestinal Agents; D010446:Peptide Fragments; D018004:Receptors, Bombesin; C071363:bombesin (6-14), Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)-; D001839:Bombesin